Elsevier

Acta Biomaterialia

Volume 5, Issue 5, June 2009, Pages 1489-1498
Acta Biomaterialia

Polysaccharide surface modified Fe3O4 nanoparticles for camptothecin loading and release

https://doi.org/10.1016/j.actbio.2008.10.022Get rights and content

Abstract

Fe3O4 nanoparticles were stabilized using different functional polysaccharides, such as chitosan (CS), O-carboxymethylchitosan (OCMCS) and (N-succinyl-O-carboxymethylchitosan (NSOCMCS) to improve their bioactivity. The release profile and the in vitro cancer cell inhibition activity of camptothecin (CPT) loaded polysaccharide modified Fe3O4 nanoparticles were systematically studies. The particle size and size distribution of CPT-loaded polysaccharide modified Fe3O4 nanoparticles were found to be strongly dependent on polysaccharide character. Such polysaccharide character could also affect CPT adsorption efficiency, CPT release behavior and bovine serum albumin (BSA) unspecific binding capacity. After 24 h incubation of 7721 cancer cells with CPT-loaded polysaccharide modified Fe3O4 nanoparticles, significant changes in cell morphology could be discernible from phase contrast microscopy. Cytotoxicity assay showed these polysaccharide modified Fe3O4 nanoparticles did not exhibit noteworthy cytotoxicity against 7721, however, the in vitro inhibition rate of CPT-loaded polysaccharide modified Fe3O4 nanoparticles against 7721 liver cancer cell increased significantly in comparison with that of CPT-free drug.

Introduction

Nanotechnology is the utilization of structures and devices with the size ranging from 1 to 100 nm, where the physical, chemical, and biological properties are significantly enhanced/changed or completely different from those of corresponding bulk materials [1]. Superparamagnetic iron oxide nanoparticles (SPION) have been extensively studied recently because of their potential biomedical applications, including in vitro cell separation, contrast agent for magnetic resonance imaging (MRI), tumor therapy or cardiovascular disease [2], [3], [4], [5], [6], [7], [8], [9], [10], [11]. Especially, for drug targeting purposes, SPION in combination with an external magnetic field allows delivering drug loaded particles to their desired target area and fixing them at the local site. Under such medication, drugs are released and act locally, which is known as magnetic drug targeting (MDT) [12], [13], [14], [15], [16]. Therefore, the dosage of medication can be reduced and the systemic effect of drugs keeps to a minimum [17], [18]. In vivo biomedical applications of SPION always require particle size less than 50 nm, which is easy to eliminate through reticuloendothelial system (RES) [19]. In addition, the particles should have their surface coated with different biocompatible materials, i.e., non-immunogenic, non-antigenic, and protein-resistant. Moreover, in order to transport such hydrophilic substance into a biological membrane system, surface modification of the nanoparticles is also a must [20].

Novel technologies in the synthesis of sophisticated coatings optimized properties of SPION have become highly attractive for medical applications in diagnostics and therapy. Three different types of magnetic colloids could be prepared through various stabilization methods [20]. One is to prepare magnetic colloids by coating magnetic core with a suitable surfactant, such as sodium oleate, dextran or PVA on SPION. Another is to synthesize nanocomposites consisting of SPION distributed throughout a non-magnetic coating like starch. The other is to form liposome-like vesicles filled with SPION. Currently, although both synthesized and natural macromolecules have been successfully used to stabilize SPION, natural macromolecules such as proteins and polysaccharides attract much more interest due to their biocompatibility and biodegradability.

Chitosan is a linear polysaccharide composed of 2-amino-2-deoxy-β-d-glucan, which has an ideal biocompatibility, biodegradability and low cytotoxicity [21]. Moreover, the chemical modification from chitosan can be instrumental in the design of novel biocompatible materials with tailored chemical and biophysical properties, because it contains both active amino and hydroxyl groups along its backbone. Recently, the stable dispersions of SPION have been successfully prepared by coated with chitosan or its biocompatible derivatives such as OCMCS [22] and NSOCMCS [23]. It has been found that the stabilization of SPION by chitosan, OCMCS and NSOCMCS is dominated by electrostatic repulsion besides steric effects.

Camptothecin (CPT), a plant alkaloid isolated from camptotheca acuminata, is found to be a new generation of antitumor agent. It works by inhibiting the activity of topoisomerase I [24], [25], [26]. Although CPT has been proven to be strongly effective in vitro, it has not been applied clinically due to its poor water solubility, in vivo low efficacy and severe toxic side effects at its conventional dosage forms. SPION is supposed to be an appropriate carrier to be utilized in tissue specific release, since it could effectively reduce the dosage and the systemic effect of CPT. From our previous work, we have found that the amphiphilic chitosan derivatives such as OCMCS can effectively load hydrophobic CPT and release CPT in a controlled manner due to its stimuli-responsive aggregation behavior in the aqueous media [27]. In addition, the amphiphilic character of OCMCS makes it easy to pass through the dipalmitoyl-sn-glycero-3-phosphocholine (DPPC) bilayer in physiological environment [28]. Therefore, the incorporation of CPT into amphiphilic polysaccharide coated SPION is supposed to be superior due to the synergetic effects of the unique benefit of magnetic nanoparticles and the bioactivity of amphiphilic polysaccharide surface. In this work, we prepared SPIONs with different polysaccharide surface modification and examined the effect of polysaccharide modification on the applications in drug loading and release together with the in vitro inhibition rate against cancer cells. Different from the common used steric stabilizer, the polysaccharide used are supposed to be able to not only stabilize SPION suspensions, but also facilitate to load CPT effectively, release drug in a controlled manner and improve cancer cell inhibition activity.

Section snippets

Chemicals and materials

Ferric chloride hexahydrate (FeCl3·6H2O, >99%), ferrous chloride tetrahydrate (FeCl2·4H2O, >99%), and ammonium hydroxide (29.4 wt.%) were purchased from Shanghai Chemical Reagent (China). Chitosan (CS), obtained from Lianyungang Biologicals Inc. (China), has a viscosity-averaged molecular weight of 5.2 × 105 g/mol and the degree of deacetylation of about 90%. OCMCS, containing about 100 carboxyl groups and 75 amino groups per 100 anhydroglucosamine units of chitosan, was synthesized form above CS

Preparation of CPT-loaded polysaccharide modified Fe3O4 nanoparticles

CPT undergoes a reversible pH responsive lactone to carboxylate conversion. At high pH, the labile E-ring of CPT in the lactone form opens, which resulting in the water-soluble carboxylate form. Meanwhile, the carboxylate form could convert into the water-insoluble lactone form by acidification to a neutral or low pH. During the preparation of CPT-loaded polysaccharide modified nanoparticles, the decrease in pH allows CPT opened lactone rings to close rapidly and generate lactone-formed CPT

Conclusions

CPT was chosen as a model drug and loaded into chitosan, OCMCS and NSOCMCS stabilized Fe3O4 nanoparticles. Such systems were found to be of high loading efficiency without presence of any surfactant. The CPT-loaded polysaccharide modified Fe3O4 nanoparticles had spherical shape and hydrodynamic radius ranging from 65 to 280 nm strongly depending on polysaccharide characters. The in vitro drug release from these polysaccharide modified magnetic nanoparticles exhibited a steady and sustained

Acknowledgments

The research was supported by a Natural & Scientific grant of Jiangsu Province, Project BK2006072 (China).

References (39)

  • J. Lee et al.

    Incorporation and release behavior of hydrophobic drug in functionalized poly(d,l-lactide)-block-poly(ethylene oxide) micelles

    J Control Release

    (2004)
  • C. Allen et al.

    Nano-engineering block copolymer aggregates for drug delivery

    Colloids Surf B

    (1999)
  • L. Zhang et al.

    10-Hydroxycamptothecin loaded nanoparticles: preparation and antitumor activity in mice

    J Control Release

    (2007)
  • T.C. Yeh et al.

    Intracellular labeling of T-cells with superparamagnetic contrast agents

    Magn Reson Med

    (1993)
  • R. Wessleder et al.

    Magnetically labeled cells can be detected by MR imaging

    J Magn Reson Imaging

    (1997)
  • K. Wagner et al.

    Synthesis of oligonucleotide functionalized magnetic nanoparticles and study on their in vitro cell uptake

    Appl Organomet Chem

    (2004)
  • R.F. Service

    News focus—nanomaterials show signs of toxicity

    Science

    (2003)
  • B. Ballou et al.

    Noninvasive imaging of quantum dots in mice

    Bioconjug Chem

    (2004)
  • D.R. Larson et al.

    Water-soluble quantum dots for multiphoton fluorescence imaging in vivo

    Science

    (2003)
  • Cited by (86)

    • Carboxymethylcellulose/polyacrylic acid/starch-modified Fe<inf>3</inf>O<inf>4</inf> interpenetrating magnetic nanocomposite hydrogel beads as pH-sensitive carrier for oral anticancer drug delivery system

      2021, European Polymer Journal
      Citation Excerpt :

      However, bare or non-stabilized iron oxide NPs tend to form large aggregates, impeding their integrating manner [31]. To prevent the iron oxide NPs aggregation, biopolymers as talented materials have been potentially used due to their exclusive features, such as non-toxicity, biocompatibility, biodegradability, and stimuli responsivity [32]. In this work, starch was used as an effective stabilizer to prepare stable iron oxide NPs dispersion [33].

    View all citing articles on Scopus
    View full text